United States Unfractionated Heparin Market Report 2016

Publisher Name :
Date: 10-Oct-2016
No. of pages: 122
Inquire Before Buying

Notes:

Sales, means the sales volume of Unfractionated Heparin

Revenue, means the sales value of Unfractionated Heparin

This report studies sales (consumption) of Unfractionated Heparin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Unfractionated Heparin in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Unfractionated Heparin Market Report 2016

Table of Contents
United States Unfractionated Heparin Market Report 2016
1 Unfractionated Heparin Overview
1.1 Product Overview and Scope of Unfractionated Heparin
1.2 Classification of Unfractionated Heparin
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Unfractionated Heparin
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Unfractionated Heparin (2011-2021)
1.4.1 United States Unfractionated Heparin Sales and Growth Rate (2011-2021)
1.4.2 United States Unfractionated Heparin Revenue and Growth Rate (2011-2021)
2 United States Unfractionated Heparin Competition by Manufacturers
2.1 United States Unfractionated Heparin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Unfractionated Heparin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Unfractionated Heparin Average Price by Manufactures (2015 and 2016)
2.4 Unfractionated Heparin Market Competitive Situation and Trends
2.4.1 Unfractionated Heparin Market Concentration Rate
2.4.2 Unfractionated Heparin Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Unfractionated Heparin Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Unfractionated Heparin Sales and Market Share by Type (2011-2016)
3.2 United States Unfractionated Heparin Revenue and Market Share by Type (2011-2016)
3.3 United States Unfractionated Heparin Price by Type (2011-2016)
3.4 United States Unfractionated Heparin Sales Growth Rate by Type (2011-2016)
4 United States Unfractionated Heparin Sales (Volume) by Application (2011-2016)
4.1 United States Unfractionated Heparin Sales and Market Share by Application (2011-2016)
4.2 United States Unfractionated Heparin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Unfractionated Heparin Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Unfractionated Heparin Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Unfractionated Heparin Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Unfractionated Heparin Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Unfractionated Heparin Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Unfractionated Heparin Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Unfractionated Heparin Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Unfractionated Heparin Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Unfractionated Heparin Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Unfractionated Heparin Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Unfractionated Heparin Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Unfractionated Heparin Manufacturing Cost Analysis
6.1 Unfractionated Heparin Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Unfractionated Heparin
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Unfractionated Heparin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Unfractionated Heparin Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Unfractionated Heparin Market Forecast (2016-2021)
10.1 United States Unfractionated Heparin Sales, Revenue Forecast (2016-2021)
10.2 United States Unfractionated Heparin Sales Forecast by Type (2016-2021)
10.3 United States Unfractionated Heparin Sales Forecast by Application (2016-2021)
10.4 Unfractionated Heparin Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Unfractionated Heparin
Table Classification of Unfractionated Heparin
Figure United States Sales Market Share of Unfractionated Heparin by Type in 2015
Table Application of Unfractionated Heparin
Figure United States Sales Market Share of Unfractionated Heparin by Application in 2015
Figure United States Unfractionated Heparin Sales and Growth Rate (2011-2021)
Figure United States Unfractionated Heparin Revenue and Growth Rate (2011-2021)
Table United States Unfractionated Heparin Sales of Key Manufacturers (2015 and 2016)
Table United States Unfractionated Heparin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Unfractionated Heparin Sales Share by Manufacturers
Figure 2016 Unfractionated Heparin Sales Share by Manufacturers
Table United States Unfractionated Heparin Revenue by Manufacturers (2015 and 2016)
Table United States Unfractionated Heparin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Unfractionated Heparin Revenue Share by Manufacturers
Table 2016 United States Unfractionated Heparin Revenue Share by Manufacturers
Table United States Market Unfractionated Heparin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Unfractionated Heparin Average Price of Key Manufacturers in 2015
Figure Unfractionated Heparin Market Share of Top 3 Manufacturers
Figure Unfractionated Heparin Market Share of Top 5 Manufacturers
Table United States Unfractionated Heparin Sales by Type (2011-2016)
Table United States Unfractionated Heparin Sales Share by Type (2011-2016)
Figure United States Unfractionated Heparin Sales Market Share by Type in 2015
Table United States Unfractionated Heparin Revenue and Market Share by Type (2011-2016)
Table United States Unfractionated Heparin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Unfractionated Heparin by Type (2011-2016)
Table United States Unfractionated Heparin Price by Type (2011-2016)
Figure United States Unfractionated Heparin Sales Growth Rate by Type (2011-2016)
Table United States Unfractionated Heparin Sales by Application (2011-2016)
Table United States Unfractionated Heparin Sales Market Share by Application (2011-2016)
Figure United States Unfractionated Heparin Sales Market Share by Application in 2015
Table United States Unfractionated Heparin Sales Growth Rate by Application (2011-2016)
Figure United States Unfractionated Heparin Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Unfractionated Heparin Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Unfractionated Heparin Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Unfractionated Heparin Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Unfractionated Heparin Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Unfractionated Heparin Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Unfractionated Heparin Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Unfractionated Heparin Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Unfractionated Heparin Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Unfractionated Heparin Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Unfractionated Heparin Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Unfractionated Heparin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Unfractionated Heparin
Figure Manufacturing Process Analysis of Unfractionated Heparin
Figure Unfractionated Heparin Industrial Chain Analysis
Table Raw Materials Sources of Unfractionated Heparin Major Manufacturers in 2015
Table Major Buyers of Unfractionated Heparin
Table Distributors/Traders List
Figure United States Unfractionated Heparin Production and Growth Rate Forecast (2016-2021)
Figure United States Unfractionated Heparin Revenue and Growth Rate Forecast (2016-2021)
Table United States Unfractionated Heparin Production Forecast by Type (2016-2021)
Table United States Unfractionated Heparin Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • United States Clinical Reference Laboratory Services Market Report 2017
    Published: 26-Apr-2017        Price: US 3800 Onwards        Pages: 114
    Notes: Sales, means the sales volume of Clinical Reference Laboratory Services Revenue, means the sales value of Clinical Reference Laboratory Services This report studies sales (consumption) of Clinical Reference Laboratory Services in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - SCTC - Kingmed - Adicon - DIAN DIAGNOSTICS - Kindstar - DAAN GENE......
  • Global Shelf Pessary Market Size, Status and Forecast 2022
    Published: 26-Apr-2017        Price: US 3300 Onwards        Pages: 95
    This report studies the global Shelf Pessary market, analyzes and researches the Shelf Pessary development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - CooperSurgical - MedGyn - Personal Medical Corp - Integra LifeSciences - Panpac Medical - Medesign - Smiths Medical - Thomas Medical - Kangge Medical - Dr. Arabin ......
  • Global Ring Pessary Market Size, Status and Forecast 2022
    Published: 26-Apr-2017        Price: US 3300 Onwards        Pages: 91
    This report studies the global Ring Pessary market, analyzes and researches the Ring Pessary development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - CooperSurgical - MedGyn - Personal Medical Corp - Integra LifeSciences - Panpac Medical - Medesign - Smiths Medical - Thomas Medical - Kangge Medical - Dr. Arabin ......
  • Global Generic Drugs Market Research Report 2017
    Published: 26-Apr-2017        Price: US 2900 Onwards        Pages: 127
    In this report, the global Generic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Generic Drugs in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan......
  • Global Renal Biomarkers Market Report 2017
    Published: 26-Apr-2017        Price: US 2999 Onwards        Pages: 126
    This report studies the Renal Biomarkers market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Renal Biomarkers market by product type and applications/end industries. The global Renal Biomarkers market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016......
  • Global Video Laparoscopes Market Research Report 2017
    Published: 26-Apr-2017        Price: US 2900 Onwards        Pages: 101
    In this report, the global Video Laparoscopes market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Video Laparoscopes in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China ......
  • Global Surgical Needle Market Research Report 2017
    Published: 26-Apr-2017        Price: US 2900 Onwards        Pages: 111
    In this report, the global Surgical Needle market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Surgical Needle in these regions, from 2012 to 2022 (forecast), covering - North America - Europe China Japan......
  • Global Celecoxib Market Research Report 2017
    Published: 26-Apr-2017        Price: US 2900 Onwards        Pages: 103
    In this report, the global Celecoxib market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Celecoxib in these regions, from 2012 to 2022 (forecast), covering - North America - Europe China Japan - Sout......
  • Global Cellulite Treatment Market Research Report 2017
    Published: 26-Apr-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Cellulite Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Cellulite Treatment in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs